Table 2.

List of S. cerevisiae ‘omics datasets with a brief description of methodology. A total of two studies include C. glabrata datasets. (Abbreviations: 5-FC, 5-flucytosine; FCZ, fluconazole; MCN, miconazole; CTZ, clotrimazole; KCZ, ketoconazole; ICZ, itraconazole; CSP, caspofungin and AmB, amphotericin B.)

Citation	Species	Analysis	Strain	Drug	Methods details
Zhang et al. (2002)	S. cerevisiae	Transcriptomics (Microarray)	L1190	5-FC, 25 µg/mL	OD600 ∼0.8, 30°C YPD, exposed to 5-FC for 90 min, n = 1
				(0.5x MIC100)
Agarwal et al. (2003)	S. cerevisiae	Transcriptomics (Microarray)	S288c	AmB, 0.12 µg/mL	OD600 ∼0.2, 30°C, SD, exposed to drug for 3 h, n = 2
				5-FC, 0.3 µg/mL
				CSP, 0.02 µg/mL
				KCZ, 56 µg/mL
Reinoso-Martin et al. (2003)	S. cerevisiae	Transcriptomics (Microarray)	BY4741	CSP, 10 ng/mL	OD600 ∼1, 30°C YPD, exposed to CSP for 1, 2 and 3 h, n = 4
Kuo et al. (2010)	S. cerevisiae,	Transcriptomics (Microarray)	BY4741	FCZ, 4 µg/mL (MIC50)	OD600 ∼0.05–0.2, 30°C YPD, cells
	C. glabrata		CBS138		harvested 0, 1/3, 2/3, 1, 2 or 4 doubling times, n = 3
Nishikawa et al. (2016)	S. cerevisiae,	Transcriptomics (RNA-Seq)	BY4741	KCZ, 40 µM	OD600 ∼0.8, 30°C YPD, treated with DMSO 8 h, then KCZ for 15 min; n = 3
	C. glabrata		DSY562
Pang et al. (2017)	S. cerevisiae	Transcriptomics (RNA-Seq)	S288c	AmB, 0.03 µg/mL	30°C RPMI-1640, 50–60 min drug treatment; n = 3
Garcia et al. (2017)	S. cerevisiae	Transcriptomics (Microarray)	BY4741	CSP, 15 ng/mL	OD600 ∼0.2, 30°C YPD, 2 h drug treatment; n = 3
ATripathi et al. (2020)	S. cerevisiae	Transcriptomics (RNA-Seq)	S288c	CSP, 0.03 µg/mL	OD600 ∼0.1, 30°C SD +/− drug for ∼4 h, n = 3
Messner et al. (2021)	S. cerevisiae	Proteomics (ScanningSWATH)	BY4741	MCN, KCZ, ICZ and CTZ, 10 µM	Overnight 30°C SD transferred to 96-well plate, exposed to drug overnight; n = 3–4